SCHEDULE: Kanen Group Amends EGAIN Stake, Philotimo Sells Shares

An amendment to Schedule 13D reveals that the Kanen Group, including Philotimo Fund, LP, holds a 7.6% stake in EGAIN Corp, with Philotimo Fund, LP having sold 675,577 shares over the past sixty days.

Summary

• Kanen Wealth Management LLC and its affiliates, including Philotimo Fund, LP and Philotimo Focused Growth & Income Fund, collectively beneficially own 2,047,683 shares of EGAIN Corp, representing approximately 7.6% of the outstanding common stock.
• This filing is Amendment No. 4 to the Schedule 13D.
• Philotimo Fund, LP sold a total of 675,577 shares of EGAIN Corp common stock in open market transactions between September 4, 2025, and October 8, 2025, at prices ranging from $3.9543 to $13.1259 per share.
• As of October 8, 2025, Philotimo Fund, LP beneficially owned 1,056,031 shares (3.9%), Philotimo Focused Growth & Income Fund owned 734,187 shares (2.7%), Kanen Wealth Management LLC owned 2,025,254 shares (7.5%), and David Kanen owned 2,047,683 shares (7.6%).
• The shares were purchased using working capital or funds for customer accounts, potentially including margin loans.

Sentiment

Score: 4

Explanation: The significant selling activity by Philotimo Fund, LP, a component of the Kanen Group, suggests a reduction in conviction or a strategic divestment, which could be viewed negatively by the market. While the overall group still holds a substantial stake, the recent sales are a bearish signal from this specific entity.

Positives

• The Kanen Group maintains a significant beneficial ownership stake of 7.6% in EGAIN Corp, indicating continued interest in the company.

Negatives

• Philotimo Fund, LP, a key entity within the Kanen Group, significantly reduced its direct holdings by selling 675,577 shares over the past 60 days.
• The sales occurred across a range of prices, including higher price points, suggesting a decision to realize gains or reduce exposure.

Risks

• Significant selling activity by a major beneficial owner like Philotimo Fund, LP could signal a lack of confidence or a strategic shift, potentially impacting investor sentiment.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding EGAIN Corp's future performance or strategic direction.

Industry Context

This filing primarily concerns changes in beneficial ownership by an investment group and does not provide information directly related to broader industry trends or competitive landscape for EGAIN Corp. However, significant selling by an activist investor group could draw attention from other market participants.

Comparison to Industry Standards

• This Schedule 13D/A filing is a disclosure of beneficial ownership and related transactions, not a performance report. Therefore, it does not contain information that allows for a direct comparison to industry-specific benchmarks or competitor results.

Stakeholder Impact

• Shareholders: The selling activity by Philotimo Fund, LP could lead to negative sentiment and potential downward pressure on EGAIN Corp's stock price.
• Investment Community: The amendment provides updated transparency on the holdings and recent trading activity of a notable investment group, which is crucial for market analysis.

Next Steps

• The filing does not explicitly mention any future actions, events, or milestones for EGAIN Corp or the reporting persons beyond the disclosure of current ownership.

Key Dates

Recommendation

While a significant portion of the Kanen Group's stake remains, the substantial selling by Philotimo Fund, LP over the past 60 days introduces uncertainty. This divestment by a key entity within an activist group could signal a shift in their investment thesis or a decision to reallocate capital. Investors should hold to observe if this selling trend continues or if other members of the group initiate further actions, and await further clarity on the group's long-term intentions and EGAIN Corp's performance.

Keywords

EGAIN Corp, Schedule 13D/A, Beneficial Ownership, Philotimo Fund, Kanen Wealth Management, Stock Sales, Institutional Investor, Shareholder Activity, Common Stock